Nuvectis Pharma (NVCT)
(Delayed Data from NSDQ)
$6.42 USD
-0.16 (-2.43%)
Updated May 29, 2024 04:00 PM ET
After-Market: $6.39 -0.03 (-0.47%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth C Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/14/2024
Time: -- |
6/2024 | $-0.26 | 0.00% |
Earnings Summary
For their last quarter, Nuvectis Pharma (NVCT) reported earnings of -$0.25 per share, beating the Zacks Consensus Estimate of $-0.40 per share. This reflects a positive earnings surprise of 37.50%. Look out for NVCT's next earnings release expected on August 14, 2024. For the next earning release, we expect the company to report earnings of -$0.26 per share, reflecting a year-over-year increase of 31.58%.
Earnings History
Price & Consensus
Zacks News for NVCT
Down -36.49% in 4 Weeks, Here's Why You Should You Buy the Dip in Nuvectis Pharma, Inc. (NVCT)
NVCT: What are Zacks experts saying now?
Zacks Private Portfolio Services